Palaniappan Jyoti 4
4 · Adaptive Biotechnologies Corp · Filed Apr 21, 2021
Insider Transaction Report
Form 4
Palaniappan Jyoti
SVP, Diagnostics, immunoSEQ Dx
Transactions
- Sale
Common Stock
2021-04-19$41.25/sh−1,301$53,666→ 9,158 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-04-19−1,301→ 107,647 totalExercise: $22.55Exp: 2030-03-19→ Common Stock (1,301 underlying) - Exercise/Conversion
Common Stock
2021-04-19$22.55/sh+1,301$29,338→ 10,459 total
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2020.
- [F2]The options vested with respect to 1/4 of such shares on March 18, 2021, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.